Your Location:
Home >
Browse articles >
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
- Military Medical Research Vol. 10, Issue 2, Pages: 227-241(2023)
DOI: 10.1186/s40779-022-00410-2
Scan QR Code
Full Text(HTML)
Figs( 2 ) Tabs( 3 )
References
Publication Info
Metrics
38
Views
25
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Frostbite: diagnosis, treatment, prognosis, and future directions
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
Related Author
No data
Related Institution
No data

